Liposomal formulations of thrombomodulin increase engraftment after intraportal islet transplantation

Cell Transplantation

Volumn 19, Issue 11, 2010, Pages 1359-1367

  Cui, Wanxing ^a   Angsana, Julianty ^b   Wen, Jing ^a   Chaikof, Elliot L ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Emory University   (United States)

^c Georgia Institute of Technology   (United States)

Author keywords

Engraftment; Inflammation; Islet transplantation; Thrombomodulin; Thrombosis

Indexed keywords

FIBRIN; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DRUG FORMULATION; ENGRAFTMENT; FIBRIN DEPOSITION; GRAFT RECIPIENT; HISTOPATHOLOGY; INFLAMMATION; INSTANT BLOOD MEDIATED INFLAMMATORY REACTION; LIVER TRANSPLANTATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; DIABETES MELLITUS, EXPERIMENTAL; FIBRIN; GRAFT SURVIVAL; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIPOSOMES; LIVER; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; NF-KAPPA B; THROMBOMODULIN; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 78651483943     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X513964     Document Type: Article

References (78)

1. Aoki, Y.; Ohishi, R.; Takei, R.; Matsuzaki, O.; Mohri, M.; Saitoh, K.; Gomi, K.; Sugihara, T.; Kiyota, T.; Yamamoto, S. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb. Haemost. 71(4):452-455; 1994.
2. Aoki, Y.; Takei, R.; Mohri, M.; Gonda, Y.; Gomi, K.; Sugihara, T.; Kiyota, T.; Yamamoto, S.; Ishida, T.; Maruyama, I. Antithrombotic effects of recombinant human soluble thrombomodulin (rhs-TM) on arteriovenous shunt thrombosis in rats. Am. J. Hematol. 47(3):162-166; 1994.
3. Arita, S.; Une, S.; Ohtsuka, S.; Atiya, A.; Kasraie, A.; Shevlin, L.; Mullen, Y. Prevention of primary islet isograft nonfunction in mice with pravastatin. Transplantation 65(11):1429-1433; 1998.
4. Barshes, N. R.; Wyllie, S.; Goss, J. A. Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: Implications for intrahepatic grafts. J. Leukoc. Biol. 77(5):587-597; 2005.
5. Bennet, W.; Groth, C. G.; Larsson, R.; Nilsson, B.; Korsgren, O. Isolated human islets trigger an instant blood mediated inflammatory reaction: Implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes. Ups. J. Med. Sci. 105(2):125-133; 2000.
6. Bennet, W.; Sundberg, B.; Groth, C. G.; Brendel, M. D.; Brandhorst, D.; Brandhorst, H.; Bretzel, R. G.; Elgue, G.; Larsson, R.; Nilsson, B.; Korsgren, O. Incompatibility between human blood and isolated islets of Langerhans: A finding with implications for clinical intraportal islet transplantation? Diabetes 48(10):1907-1914; 1999.
7. Berg, D. T.; Gerlitz, B.; Shang, J.; Smith, T.; Santa, P.; Richardson, M. A.; Kurz, K. D.; Grinnell, B. W.; Mace, K.; Jones, B. E. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties. Proc. Natl. Acad. Sci. USA 100(8):4423-4428; 2003.
8. Berman, D. M.; Cabrera, O.; Kenyon, N. M.; Miller, J.; Tam, S. H.; Khandekar, V. S.; Picha, K. M.; Soderman, A. R.; Jordan, R. E.; Bugelski, P. J.; Horninger, D.; Lark, M.; Davis, J. E.; Alejandro, R.; Berggren, P. O.; Zimmerman, M.; O'Neil, J. J.; Ricordi, C.; Kenyon, N. S. Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass model. Transplantation 84(3):308-315; 2007.
9. Blakely, M. L.; Van der Werf, W. J.; Berndt, M. C.; Dalmasso, A. P.; Bach, F. H.; Hancock, W. W. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58(10):1059-1066; 1994.
10. Bottino, R.; Fernandez, L. A.; Ricordi, C.; Lehmann, R.; Tsan, M. F.; Oliver, R.; Inverardi, L. Transplantation of allogeneic islets of Langerhans in the rat liver: Effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47(3):316-323; 1998.
11. Campbell, W. D.; Lazoura, E.; Okada, N.; Okada, H. Inactivation of C3a and C5a octapeptides by carboxypeptidase R and carboxypeptidase N. Microbiol. Immunol. 46(2): 131-134; 2002.
12. Cicala, C.; Cirino, G. Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk. Life Sci. 62(20):1817-1824; 1998.
13. Contreras, J. L.; Eckstein, C.; Smyth, C. A.; Bilbao, G.; Vilatoba, M.; Ringland, S. E.; Young, C.; Thompson, J. A.; Fernandez, J. A.; Griffin, J. H.; Eckhoff, D. E. Activated protein C preserves functional islet mass after intraportal transplantation: A novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes 53(11):2804-2814; 2004.
14. Conway, E. M.; Van de Wouwer, M.; Pollefeyt, S.; Jurk, K.; Van Aken, H.; De Vriese, A.; Weitz, J. I.; Weiler, H.; Hellings, P. W.; Schaeffer, P.; Herbert, J. M.; Collen, D.; Theilmeier, G. The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J. Exp. Med. 196(5):565-577; 2002.
15. Coughlin, S. R. Thrombin signalling and protease-activated receptors. Nature 407:258-264; 2000.
16. Cui, W.; Barr, G.; Faucher, K. M.; Sun, X. L.; Safley, S. A.; Weber, C. J.; Chaikof, E. L. A membane-mimetic barrier for islet encapsulation. Transplant. Proc. 36(4): 1206-1208; 2004.
17. Davalli, A. M.; Ogawa, Y.; Ricordi, C.; Scharp, D. W.; Bonner-Weir, S.; Weir, G. C. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 59(6):817-820; 1995.
18. Davalli, A. M.; Scaglia, L.; Zangen, D. H.; Hollister, J.; Bonner-Weir, S.; Weir, G. C. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 45(9):1161-1167; 1996.
19. Dugina, T. N.; Kiseleva, E. V.; Chistov, I. V.; Umarova, B. A.; Strukova, S. M. Receptors of the PAR family as a link between blood coagulation and inflammation. Biochemistry (Mosc.) 67(1):65-74; 2002.
20. Esmon, C. T. Coagulation and inflammation. J. Endotoxin Res. 9(3):192-198; 2003.
21. Esmon, C. T. Crosstalk between inflammation and thrombosis. Maturitas 47(4):305-314; 2004.
22. Esmon, C. T. Inflammation and the activated protein C anticoagulant pathway. Semin. Thromb. Hemost. 32(Suppl. 1):49-60; 2006.
23. Esmon, C. T. Inflammation and thrombosis: The impact of inflammation on the protein C anticoagulant pathway. Haematologica 80(2 Suppl.):49-56; 1995.
24. Esmon, C. T. Role of coagulation inhibitors in inflammation. Thromb. Haemost. 86(1):51-56; 2001.
25. Esmon, C. T. The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway. J. Autoimmun. 15(2):113-116; 2000.
26. Esmon, C. T. The impact of the inflammatory response on coagulation. Thromb. Res. 114(5-6):321-327; 2004.
27. Esmon, C. T. The interactions between inflammation and coagulation. Br. J. Haematol. 131(4):417-430; 2005.
28. Esmon, C. T. The normal role of activated protein C in maintaining homeostasis and its relevance to critical illness. Crit. Care 5(2):S7-12; 2001.
29. Esmon, C. T.; Fukudome, K.; Mather, T.; Bode, W.; Regan, L. M.; Stearns-Kurosawa, D. J.; Kurosawa, S. Inflammation, sepsis, and coagulation. Haematologica 84(3):254-259; 1999.
30. Fernandez, L.; Bottino, R.; Oliver, R.; Lehmann, R.; Ricordi, C.; Fu Tsan, M.; Inverardi, L. Endothelial cell dysfunction after intraportal islet cell transplant in rats. Transplant. Proc. 29(4):2064-2065; 1997.
31. Fontaine, M. J.; Blanchard, J.; Rastellini, C.; Lazda, V.; Herold, K. C.; Pollak, R. Pancreatic islets activate portal vein endothelial cells in vitro. Ann. Clin. Lab. Sci. 32(4):352-361; 2002.
32. Fourrier, F. Recombinant human activated protein C in the treatment of severe sepsis: An evidence-based review. Crit. Care Med. 32(11 Suppl.):S534-541; 2004.
33. Froberg, M. K.; Leone, J. P.; Jessurun, J.; Sutherland, D. E. Fatal disseminated intravascular coagulation after autologous islet transplantation. Hum. Pathol. 28:1295-1298; 1997.
34. Geudens, N.; Van de Wouwer, M.; Vanaudenaerde, B. M.; Vos, R.; Van De Wauwer, C.; Verleden, G. M.; Verbeken, E.; Lerut, T.; Van Raemdonck, D. E.; Conway, E. M. The lectin-like domain of thrombomodulin protects against ischaemia-reperfusion lung injury. Eur. Respir. J. 32(4):862-870; 2008.
35. Gonda, Y.; Hirata, S.; Saitoh, K.; Aoki, Y.; Mohri, M.; Gomi, K.; Sugihara, T.; Kiyota, T.; Yamamoto, S.; Ishida, T. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb. Res. 71(4):325-335; 1993.
36. Goto, M.; Groth, C. G.; Nilsson, B.; Korsgren, O. Intraportal pig islet xenotransplantation into athymic mice as an in vivo model for the study of the instant blood-mediated inflammatory reaction. Xenotransplantation 11(2):195-202; 2004.
37. Goto, M.; Johansson, H.; Maeda, A.; Elgue, G.; Korsgren, O.; Nilsson, B. Low-molecular weight dextran sulfate abrogates the instant blood-mediated inflammatory reaction induced by adult porcine islets both in vitro and in vivo. Transplant. Proc. 36(4):1186-1187; 2004.
38. Grey, S. T.; Hancock, W. W. A physiologic anti-inflammatory pathway based on thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J. Immunol. 156(6):2256-2263; 1996.
39. Grey, S. T.; Tsuchida, A.; Hau, H.; Orthner, C. L.; Salem, H. H.; Hancock, W. W. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J. Immunol. 153(8):3664-3672; 1994.
40. Grinnell, B. W.; Hermann, R. B.; Yan, S. B. Human protein C inhibits selectin-mediated cell adhesion: Role of unique fucosylated oligosaccharide. Glycobiology 4:221-226; 1994.
41. Gruber, A.; Griffin, J. H.; Harker, L. A.; Hanson, S. R. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 73(3):639-642; 1989.
42. Haller, C. A.; Cui, W.; Wen, J.; Robson, S. C.; Chaikof, E. L. Reconstitution of CD39 in liposomes amplifies nucleoside triphsphate diphosphohydrolase activity and restores thromboregulatory properties. J. Vasc. Surg. 43(4):816-823; 2006.
43. Hancock, W. W.; Bach, F. H. Immunobiology and therapeutic applications of protein C/protein S/thrombomodulin in human and experimental allotransplantation and xenotransplantation. Trends Cardiovasc. Med. 7:174-183; 1997.
44. Hitkari, J. A.; Rowe, T. P.; von Dadelszen, P. Activated protein C and the ovarian hyperstimulation syndrome: Possible therapeutic implications. Med. Hypotheses 66(5):929-933; 2006.
45. Huang, H. C.; Shi, G. Y.; Jiang, S. J.; Shi, C. S.; Wu, C. M.; Yang, H. Y.; Wu, H. L. Thrombomodulin-mediated cell adhesion: Involvement of its lectin-like domain. J. Biol. Chem. 278(47):46750-46759; 2003.
46. Ikeguchi, H.; Maruyama, S.; Morita, Y.; Fujita, Y.; Kato, T.; Natori, Y.; Akatsu, H.; Campbell, W.; Okada, N.; Okada, H.; Yuzawa, Y.; Matsuo, S. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int. 61(2):490-501; 2002.
47. Kaufman, D. B.; Gores, P. F.; Field, M. J.; Farney, A. C.; Gruber, S. A.; Stephanian, E.; Sutherland, D. E. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43(6):778-783; 1994.
48. Kearon, C.; Comp, P.; Douketis, J.; Royds, R.; Yamada, K.; Gent, M. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J. Thromb. Haemost. 3(5):962-968; 2005.
49. Kemp, C. B.; Knight, M. J.; Scharp, D. W.; Lacy, P. E.; Ballinger, W. F. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature 244(5416):447; 1973.
50. Kenmochi, T.; Miyamoto, M.; Mullen, Y. Protection of mouse islet isografts from nonspecific inflammatory damage by recipient treatment with nicotinamide and 15-deoxyspergualin. Cell Transplant. 5(1):41-47; 1996.
51. Kumada, T.; Dittman, W. A.; Majerus, P. W. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood 71(3):728-733; 1988.
52. Levi, M.; van der Poll, T. Recombinant human activated protein C: Current insights into its mechanism of action. Crit. Care 11(Suppl. 5):S3; 2007.
53. Levi, M.; van der Poll, T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc. Med. 15(7):254-259; 2005.
54. Melzi, R.; Sanvito, F.; Mercalli, A.; Andralojc, K.; Bonifacio, E.; Piemonti, L. Intrahepatic islet transplant in the mouse: Functional and morphological characterization. Cell Transplant. 17(12):1361-1370; 2008.
55. Moberg, L.; Johansson, H.; Lukinius, A.; Berne, C.; Foss, A.; Kallen, R.; Ostraat, O.; Salmela, K.; Tibell, A.; Tufveson, G.; Elgue, G.; Nilsson Ekdahl, K.; Korsgren, O.; Nilsson, B. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 360(9350):2039-2045; 2002.
56. Mohri, M.; Oka, M.; Aoki, Y.; Gonda, Y.; Hirata, S.; Gomi, K.; Kiyota, T.; Sugihara, T.; Yamamoto, S.; Ishida, T. Intravenous extended infusion of recombinant human soluble thrombomodulin prevented tissue factor-induced disseminated intravascular coagulation in rats. Am. J. Hematol. 45(4):298-303; 1994.
57. Mosnier, L. O.; Zlokovic, B. V.; Griffin, J. H. The cytoprotective protein C pathway. Blood 109(8):3161-3172; 2007.
58. Okajima, K. Regulation of inflammatory responses by natural anticoagulants. Immunol. Rev. 184:258-274; 2001.
59. Opal, S. M. Interactions between coagulation and inflammation. Scand. J. Infect. Dis. 35(9):545-554; 2003.
60. Owen, W. G.; Esmon, C. T. Functional properties of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. J. Biol. Chem. 256(11):5532-5535; 1981.
61. Ozmen, L.; Ekdahl, K. N.; Elgue, G.; Larsson, R.; Korsgren, O.; Nilsson, B. Inhibition of thrombin aborgates the instant blood-mediated inflammatory reaction triggered by isolated human islets: Possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes 51(6):1779-1784; 2002.
62. Saito, H.; Maruyama, I.; Shimazaki, S.; Yamamoto, Y.; Aikawa, N.; Ohno, R.; Hirayama, A.; Matsuda, T.; Asakura, H.; Nakashima, M.; Aoki, N. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J. Thromb. Haemost. 5(1):31-41; 2007.
63. Scharp, D. W.; Lacy, P. E.; Santiago, J. V.; McCullough, C. S.; Weide, L. G.; Falqui, L.; Marchetti, P.; Gingerich, R. L.; Jaffe, A. S.; Cryer, P. E. Insulin independence after islet transplantation into type I diabetic patient. Diabetes 39(4):515-518; 1990.
64. Shapiro, A. M.; Lakey, J. R.; Rajotte, R. V. Portal vein thrombosis after transplantation of partially purified pancreatic islets in a combined human liver/islet allograft. Transplantation 59:1060-1063; 1995.
65. Shi, C. S.; Shi, G. Y.; Hsiao, S. M.; Kao, Y. C.; Kuo, K. L.; Ma, C. Y.; Kuo, C. H.; Chang, B. I.; Chang, C. F.; Lin, C. H.; Wong, C. H.; Wu, H. L. Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response. Blood 112(9):3661-3670; 2008.
66. Suzuki, K.; Gabazza, E. C.; Hayashi, T.; Kamada, H.; Adachi, Y.; Taguchi, O. Protective role of activated protein C in lung and airway remodeling. Crit. Care Med. 32(5 Suppl.):S262-265; 2004.
67. Taoka, Y.; Okajima, K.; Uchiba, M.; Johno, M. Neuroprotection by recombinant thrombomodulin. Thromb. Haemost. 83(3):462-468; 2000.
68. Toltl, L. J.; Swystun, L. L.; Pepler, L.; Liaw, P. C. Protective effects of activated protein C in sepsis. Thromb. Haemost. 100(4):582-592; 2008.
69. Tsiang, M.; Lentz, S. R.; Sadler, J. E. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J. Biol. Chem. 267(9):6164-6170; 1992.
70. Uchiba, M.; Okajima, K.; Murakami, K.; Johno, M.; Mohri, M.; Okabe, H.; Takatsuki, K. rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation. Am. J. Physiol. 273(4 Pt. 1):L889-894; 1997.
71. Uchiba, M.; Okajima, K.; Murakami, K.; Johno, M.; Okabe, H.; Takatsuki, K. Recombinant thrombomodulin prevents endotoxin-induced lung injury in rats by inhibiting leukocyte activation. Am. J. Physiol. 271(3 Pt. 1):L470-475; 1996.
72. Vaithilingam, V.; Sundaram, G.; Tuch, B. E. Islet cell transplantation. Curr. Opin. Organ Transplant. 13(6):633-638; 2008.
73. Van de Wouwer, M.; Collen, D.; Conway, E. M. Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation. Arterioscler. Thromb. Vasc. Biol. 24(8):1374-1383; 2004.
74. Van de Wouwer, M.; Plaisance, S.; De Vriese, A.; Waelkens, E.; Collen, D.; Persson, J.; Daha, M. R.; Conway, E. M. The lectin-like domain of thrombomodulin interferes with complement activation and protects against arthritis. J. Thromb. Haemost. 4(8):1813-1824; 2006.
75. Weiler, H.; Isermann, B. H. Thrombomodulin. J. Thromb. Haemost. 1(7):1515-1524; 2003.
76. Witkowski, P.; Zakai, S. B.; Rana, A.; Sledzinski, Z.; Hardy, M. A. Pancreatic islet transplantation, what has been achieved since Edmonton break-through. Ann. Transplant. 11(2):5-13; discussion 32-43; 2006.
77. Xenos, E. S.; Stevens, R. B.; Sutherland, D. E.; Lokeh, A.; Ansite, J. D.; Casanova, D.; Gores, P. F.; Platt, J. L. The role of nitric oxide in IL-1 beta-mediated dysfunction of rodent islets of Langerhans. Implications for the function of intrahepatic islet grafts. Transplantation 57(8):1208-1212; 1994.
78. Yin, D.; Ding, J. W.; Shen, J.; Ma, L.; Hara, M.; Chong, A. S. Liver ischemia contributes to early islet failure following intraportal transplantation: Benefits of liver ischemic-preconditioning. Am. J. Transplant. 6(1):60-68; 2006.